Serum lactate dehydrogenase activity in canine malignancies

Veterinary and Comparative Oncology

Volumn 7, Issue 4, 2009, Pages 236-243

  Marconato, L ^a   Crispino, G ^a   Finotello, R ^a   Mazzotti, S ^a   Salerni, F ^a   Zini, E ^b  

^a Clinica Veterinaria L'Arca   (Italy)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Dog; LDH; Lymphoma; Tumour marker

Indexed keywords

LACTATE DEHYDROGENASE; TUMOR MARKER;

ANIMAL; ARTICLE; BLOOD; DOG; DOG DISEASE; ENZYMOLOGY; MALE; METABOLISM; NEOPLASM;

ANIMALS; DOG DISEASES; DOGS; L-LACTATE DEHYDROGENASE; MALE; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

CANIS FAMILIARIS;

EID: 70449984927     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2009.00196.x     Document Type: Article

References (35)

1. Kim JW, Dang CV. Multifaceted roles of glycolytic enzymes. Trends in Biochemical Sciences 2005, 30:142-150.
2. Henry JB, Henry JB. Clinical enzymology. Clinical Diagnosis and Management by Laboratory Methods 1996, 281-284. In:, ed.,, Philadelphia, WB Saunders Co
3. Milne EM, Doxey DL. Lactate dehydrogenase and its isoenzymes in the tissues and sera of clinically normal dogs. Research in Veterinary Science 1987, 43:222-224.
4. Ferraris AM, Guintini P, Gaetani GF. Serum lactic dehydrogenase as a prognostic tool in non-Hodgkin's lymphomas. Blood 1979, 54:928-932.
5. Dumontet C, Drai J, Bienvenu J, Berard EN, Thieblemont C, Bouafia F, Bayle F, Moullet I, Salles G, Coiffier B. Profiles and prognostic values of LDH isoenzymes in patients with non-Hodgkin's lymphoma. Leukemia 1999, 13:811-817.
6. Kornberg A, Polliack A. Serum lactic dehydrogenase (LDH) levels in acute leukemia:marked elevations in lymphoblastic leukemia. Blood 1980, 56:351-355.
7. Muller CP, Seik L. Increased activity of a basic LDH 5-related isoenzyme in cells derived from chronic myeloid leukemia. Anticancer Research 1989, 9:559-565.
8. Venkitaraman R, Johnson B, Huddart RA, Parker CC, Horwich A, Dearnaley DP. The utility of lactate dehydrogenase in the follow-up of testicular germ cell tumours. BJU International 2007, 100:30-32.
9. Bedikian AY, Johnason MM, Warneke CL, Papadopoulos NE, Kim K, Hwu WJ, McIntyre S, Hwu P. Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma. Cancer Investigation 2008, 26:624-633.
10. Manola J, Atkins M, Ibrahim J, Kirkwood J. Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group Trials. Journal of Clinical Oncology 2000, 18:3782-3793.
11. Yüce K, Baykal C, Genç C, Al A, Ayhan A. Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. International Journal of Gynecological Cancer 2002, 12:354-361.
12. Goto A, Takeuchi S, Sugimura K, Maruo T. Diagnostic and prognostic value of serum and peritoneal fluid lactate dehydrogenase in epithelial ovarian cancer. European Journal of Gynaecological Oncology 2001, 22:228-232.
13. Pandha HS, Waxman J, Sikora K. Tumour markers. British Journal of Hospital Medicine 1994, 51:297-303.
14. Negm RS, Verma M, Srivastava S. The promise of biomarkers in cancer screening and detection. Trends in Molecular Medicine 2002, 8:288-293.
15. Matharoo-Ball B, Miles AK, Creaser CS, Ball G, Rees R. Serum biomarker profiling in cancer studies: a question of standardisation?. Veterinary and Comparative Oncology 2008, 6:224-247.
16. Zanatta R, Abate O, D'Angelo A, Miniscalco B, Mannelli A. Diagnostic and prognostic value of serum lactate dehydrogenase (LDH) and LDH isoenzymes in canine lymphoma. Veterinary Research Communications 2003, 27:449-452.
17. Hadden AG, Cotter SM, Rand W, Moore AS, Davis RM, Morrissey P. Efficacy and toxicosis of VELCAP-C treatment of lymphoma in cats. Journal of Veterinary Internal Medicine 2008, 22:153-157.
18. Nakamura N, Momoi Y, Watari T, Yoshino T, Tsujimoto H, Hasegawa A. Plasma thymidine kinase activity in dogs with lymphoma and leukemia. The Journal of Veterinary Medical Science 1997, 59:957-960.
19. von Euler HP, Ohrvik AB, Eriksson SK. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs. Research in Veterinary Science 2006, 80:17-24.
20. Shipp MA. Prognostic factors in aggressive non-Hodgkin's lymphoma: who has 'high-risk' disease?. Blood 1994, 83:1165-1173.
21. LeBlanc AK, Jacoby BW, Townsend DW, Daniel GB. 18FDG-PET imaging in canine lymphoma and cutaneous mast cell tumor. Veterinary Radiology & Ultrasound 2009, 50:215-223.
22. Chun R, Garrett LD, Vail DM, Withrow SJ, Vail DM. Withrow and Mac Ewen's Small Animal Clinical Oncology 2007, 163. In:, 4th edn., and, eds.,, St Louis, Saunders Elsevier
23. Ogilvie GK, Walters LM, Greeley SG, Henkel SE, Salman MD. Concentration of a1-acid glycoprotein in dogs with malignant neoplasia. Journal of the American Veterinary Medical Association 1993, 203:1144-1146.
24. Hahn KA, Freeman KP, Barnhill MA, Stephen EL. Serum a1-acid glycoprotein concentrations before and after relapse in dogs with lymphoma treated with doxorubicin. Journal of the American Veterinary Medical Association 1999, 214:1023-1025.
25. Tecles F, Spiranelli E, Bonfanti U, Cerón JJ, Paltrinieri S. Preliminary studies of serum acute-phase protein concentration in hematologic and neoplastic diseases of the dog. Journal of Veterinary Internal Medicine 2005, 19:865-870.
26. Mischke R, Waterston M, Eckersall PD. Changes in C-reactive protein and haptoglobin in dogs with lymphatic neoplasia. Veterinary Journal 2007, 174:188-192.
27. Merlo A, Rezende BC, Franchini ML, Simões DM, Lucas SR. Serum C-reactive protein concentrations in dogs with multicentric lymphoma undergoing chemotherapy. Journal of the American Veterinary Medical Association 2007, 230:522-526.
28. Lowseth LA, Gillett NA, Chang IY, Muggenburg BA, Boecker BB. Detection of serum alpha-fetoprotein in dogs with hepatic tumors. Journal of the American Veterinary Medical Association 1991, 199:735-741.
29. Lechowski R, Jagielski D, Hoffmann-Jagielska M, Zmudzka M, Winnicka A. Alpha-fetoprotein in canine multicentric lymphoma. Veterinary Research Communications 2002, 26:285-296.
30. Kitao S, Yamada T, Ishikawa T, Madarame H, Furuichi M, Neo S, Tsuchiya R, Kobayashi K. Alpha-fetoprotein in serum and tumor tissues in dogs with hepatocellular carcinoma. Journal of Veterinary Diagnostic Investigation 2006, 18:291-295.
31. Karayannopoulou M, Koutinas AF, Polizopoulou ZS, Roubies N, Fytianou A, Saridomichelakis MN, Kaldrymidou E. Total serum alkaline phosphatase activity in dogs with mammary neoplasms:a prospective study on 79 natural cases. Journal of Veterinary Medicine. A Physiology, Pathology, Clinical Medicine 2003, 50:501-505.
32. Karayannopoulou M, Polizopoulou ZS, Koutinas AF, Fytianou A, Roubies N, Kaldrymidou E, Tsioli V, Patsikas MN, Constantinidis TC, Koutinas CK. Serum alkaline phosphatase isoenzyme activities in canine malignant mammary neoplasms with and without osseous transformation. Veterinary Clinical Pathology 2006, 35:287-290.
33. Poli A, Arispici M, Camillo F, Corazza M. Increase of serum lipid-associated sialic acid concentration in dogs with neoplasms. American Journal of Veterinary Research 1986, 47:607-609.
34. Wang TS, Johnson TM, Cascade PN, Redman BG, Sondak VK, Schwartz JL. Evaluation of staging chest radiographs and serum lactate dehydrogenase for localized melanoma. Journal of the American Academy of Dermatology 2004, 51:399-405.
35. Greenlee PG, Filippa DA, Quimby FW, Patnaik AK, Calvano SE, Matus RE, Kimmel M, Hurvitz AI, Lieberman PH. Lymphomas in dogs. A morphologic, immunologic, and clinical study. Cancer 1990, 66:480-490.